Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
Clinical trial NCT03415802 · COMPLETED
Trial details
- NCT number
- NCT03415802
- Sponsor
- Aiping Zhou
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-11
- Primary completion
- 2017-07-11
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.